Allogene Therapeutics Return on Net Operating Assets Insights

Allogene Therapeutics, Inc. (ALLO)

1.63 +0.02 (+1.24%) USD | NASDAQ | Jan 16, 16:00

1.63 0.00 (0.00%) After-Hours: 20:00

View Return on Net Operating Assets for ALLO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

ANI Pharmaceuticals, Inc.	Upgrade
AIM ImmunoTech, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Protalix Biotherapeutics, Inc.	Upgrade
Armata Pharmaceuticals, Inc.	Upgrade